Results 31 to 40 of about 402,905 (265)

Construction of online and offline combined gynecological specialist nurse training program

open access: yesHuli yanjiu, 2022
ObjectiveTo construct an online and offline combined training program for gynecological specialist nurses and provide the reference for the training of gynecological specialist nurses in China.MethodsBased on the job competency as the theoretical basis ...
HU Yan, WANG Fulan, LUO Yueying, WANG Li
doaj  

Patient involvement in research within the Gynecological Cancer InterGroup: A call to action for a systematic approach: Results from a survey

open access: yesHealth Science Reports, 2023
Background and Aims Involving patients in research, not only as trial subjects, is not a newly established practice. Over the last two decades, patient roles have gradually expanded to become active research contributors, creating a more patient‐centered
Ivana Nohová   +5 more
doaj   +1 more source

Cancer cell‐intrinsic type 1 interferon: production, signaling, and outcomes within sex‐biased, female malignancies

open access: yesMolecular Oncology, EarlyView.
The cell‐autonomous roles of interferon type 1 vary based on duration and intensity. While acute, robust signaling results in cancer cell cytotoxic effects, sustained, low‐level signaling is associated with tumor‐promoting effects. This review summarizes current research of IFN‐1 in cancer and within the clinical setting, with an emphasis on female ...
Ashlyn Conant   +7 more
wiley   +1 more source

Addressing Economic Insecurities Can Improve Patient‐Reported Outcomes in Lupus

open access: yesArthritis Care &Research, EarlyView.
Objective Economic insecurities, such as food, housing, transportation, and financial challenges, are modifiable risk factors and influence patient‐reported outcomes (PROs) in systemic lupus erythematosus (SLE). We examined the following: (1) associations between economic insecurities and PROs, and (2) the impact of screening and addressing economic ...
Jay Patel   +8 more
wiley   +1 more source

PROSPECTS OF CLINICAL USE OF OFLOXACIN IN GYNECOLOGY AND UROLOGY

open access: yesАнтибиотики и Химиотерапия, 2020
The review provides the present Russian and international data on the effectiveness of ofloxacin. The drug is effective and safe in the treatment of various pathologies.
A. A. Khryanin, O. V. Reshetnikov
doaj  

ELECTRICITY IN GYNECOLOGY [PDF]

open access: yesThe American Journal of the Medical Sciences, 1889
n ...
openaire   +2 more sources

Prevalence of Systemic Lupus Erythematosus in Australia, 2010–2022: A Population‐Based Study Using Linked National Administrative Health Data

open access: yesArthritis Care &Research, EarlyView.
Objective Systemic lupus erythematosus (SLE) is a heterogenous inflammatory condition with widely varying global prevalence estimates. The frequency of SLE in the general population of Australia has been reported to be notably lower than contemporary estimates in countries such as the United States or United Kingdom, at 19 to 39 per 100,000 as opposed ...
Lucinda Roper   +7 more
wiley   +1 more source

Isoflavones in gynecology [PDF]

open access: yesRevista da Associação Médica Brasileira, 2018
SUMMARY
Carbonel, Adriana Aparecida Ferraz   +8 more
openaire   +4 more sources

Building a Framework for Sexual and Reproductive Health Care in the Rheumatology Context: Content and Approaches

open access: yesArthritis Care &Research, EarlyView.
People with systemic autoimmune and rheumatic diseases (SARDs) are at higher risk than the general population of experiencing adverse pregnancy and perinatal outcomes such as preeclampsia, intrauterine growth restriction, and maternal and/or fetal death.
Mehret Birru Talabi, Sonya Borrero
wiley   +1 more source

Evaluating Cervical Cancer Risk Using Machine Learning

open access: yesHaseki Tıp Bülteni
Aim: Cervical cancer development is influenced by a complex interaction of socio-demographic, behavioral, and clinical factors, which can be systematically analyzed using large datasets.
Tugba Muhlise Okyay   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy